Christopher Ogden Cytom X Therapeutics, Inc. (CTMX) insider trading activity
Christopher Ogden is Chief Financial Officer of CytomX Therapeutics, Inc.. Currently has a direct ownership of 201,026 shares of CTMX, which is worth approximately $134,687. The most recent transaction as insider was on Mar 18, 2025, when has been sold 8,551 shares (Common Stock) at a price of $0.6 per share, resulting in proceeds of $5,130. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
201K
86.0%
3M change
134.61%
12M change
Total Value Held
$134,687
Christopher Ogden Transaction History
CO
Christopher Ogden
Chief Financial Officer
South San Francisco, CA